Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,837 | -16,514 | -7,659 | -7,484 | -41,595 |
| Depreciation Amortization | 860 | 658 | 487 | 241 | 954 |
| Income taxes - deferred | -285 | -240 | -52 | 52 | -133 |
| Accounts receivable | -1,032 | -827 | -1,009 | -824 | -653 |
| Other Working Capital | -26,089 | -23,290 | -19,598 | -7,132 | 33,520 |
| Other Operating Activity | 7,259 | 5,203 | 3,975 | 2,080 | 3,193 |
| Operating Cash Flow | $-48,124 | $-35,010 | $-23,856 | $-13,067 | $-4,714 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,187 | -58,214 | -40,975 | -52,278 | -64,969 |
| PPE Investments | -2,637 | -1,809 | -1,016 | -647 | -1,240 |
| Investing Cash Flow | $-16,824 | $-60,023 | $-41,991 | $-52,925 | $-66,209 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -16,743 | -16,743 | -16,743 | N/A | N/A |
| Common Stock Issued | 102,538 | 102,493 | 102,493 | 102,470 | 27,518 |
| Financing Cash Flow | $85,795 | $85,750 | $85,750 | $102,470 | $27,518 |
| Exchange Rate Effect | -593 | -372 | -459 | -725 | 406 |
| Beginning Cash Position | 24,755 | 24,755 | 24,755 | 24,755 | 67,754 |
| End Cash Position | 45,009 | 15,100 | 44,199 | 60,508 | 24,755 |
| Net Cash Flow | $20,254 | $-9,655 | $19,444 | $35,753 | $-42,999 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,124 | -35,010 | -23,856 | -13,067 | -4,714 |
| Capital Expenditure | -2,637 | -1,809 | -1,016 | -647 | -1,240 |
| Free Cash Flow | -50,761 | -36,819 | -24,872 | -13,714 | -5,954 |